Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
- Published In:
- BMC microbiology, 19(1), 54 (2019)
- Database ID:
- RPEP-04187
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04187APA
Geitani, Regina; Ayoub Moubareck, Carole; Touqui, Lhousseine; Karam Sarkis, Dolla. (2019). Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.. BMC microbiology, 19(1), 54. https://doi.org/10.1186/s12866-019-1416-8
MLA
Geitani, Regina, et al. "Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.." BMC microbiology, 2019. https://doi.org/10.1186/s12866-019-1416-8
RethinkPeptides
RethinkPeptides Research Database. "Cationic antimicrobial peptides: alternatives and/or adjuvan..." RPEP-04187. Retrieved from https://rethinkpeptides.com/research/geitani-2019-cationic-antimicrobial-peptides-alternatives
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.